Cellergy Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $22M

  • Investors
  • 6

Cellergy Therapeutics General Information

Description

Operator of a biotechnology company intended to transform human health. The company is making a mitochondrial product for systemic repeated administration with fully matched allogeneic purified mitochondria, in IV administration for large systemic indications such as CNS, muscle degeneration, and aging, enabling patients to help energize cells, fight degenerative diseases and enhance healthy longevity.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 13 Lilinblum
  • Tel Aviv 6513202
  • Israel
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 13 Lilinblum
  • Tel Aviv 6513202
  • Israel

Cellergy Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellergy Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series A) 01-Jul-2026 $22M Completed Generating Revenue
1. Early Stage VC 20-Nov-2025 Completed Generating Revenue
To view Cellergy Therapeutics’s complete valuation and funding history, request access »

Cellergy Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed Shares
Seed-1 Shares
Seed-2 Shares 226,939 $0.010000 $6.32 $6.32 1x $6.32 38.91%
To view Cellergy Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cellergy Therapeutics Patents

Cellergy Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024226639-A1 Mitochondria isolation from cells in suspension Pending 23-Feb-2023
EP-4669326-A1 Mitochondria isolation from cells in suspension Pending 23-Feb-2023
US-20240409877-A1 Mitochondria isolation from cells in suspension Pending 23-Feb-2023
WO-2024176236-A1 Mitochondria isolation from cells in suspension Inactive 23-Feb-2023 C12N1/066

Cellergy Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cellergy Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aliya Capital PE/Buyout Minority
Pershing Square Foundation Not-For-Profit Venture Capital Minority
Rotcan Holdings Corporation Minority
Schneider Children's VC Venture Capital Minority
ENKORE International Enterprises Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Cellergy Therapeutics FAQs

  • When was Cellergy Therapeutics founded?

    Cellergy Therapeutics was founded in 2021.

  • Where is Cellergy Therapeutics headquartered?

    Cellergy Therapeutics is headquartered in Tel Aviv, Israel.

  • What is the size of Cellergy Therapeutics?

    Cellergy Therapeutics has 6 total employees.

  • What industry is Cellergy Therapeutics in?

    Cellergy Therapeutics’s primary industry is Biotechnology.

  • Is Cellergy Therapeutics a private or public company?

    Cellergy Therapeutics is a Private company.

  • What is the current valuation of Cellergy Therapeutics?

    The current valuation of Cellergy Therapeutics is .

  • What is Cellergy Therapeutics’s current revenue?

    The current revenue for Cellergy Therapeutics is .

  • How much funding has Cellergy Therapeutics raised over time?

    Cellergy Therapeutics has raised $25.6M.

  • Who are Cellergy Therapeutics’s investors?

    Aliya Capital, Pershing Square Foundation, Rotcan Holdings, Schneider Children's VC, and ENKORE International Enterprises are 5 of 6 investors who have invested in Cellergy Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process